Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy
Isabella Giacomini, Federico Gianfanti, María Andrea Desbats, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 87

Showing 26-50 of 87 citing articles:

Lipid metabolism dysregulation for bone metastasis and its prevention
Jyoti Poswal, Chandi C. Mandal
Expert Review of Anticancer Therapy (2025)
Closed Access
Lipid Alterations in Glioma: A Systematic Review
Khairunnisa Abdul Rashid, Kamariah Ibrahim, Jeannie Hsiu Ding Wong, et al.
Metabolites (2022) Vol. 12, Iss. 12, pp. 1280-1280
Open Access | Times Cited: 18
Impact of De Novo Cholesterol Biosynthesis on the Initiation and Progression of Breast Cancer
Danila Coradini
Biomolecules (2024) Vol. 14, Iss. 1, pp. 64-64
Open Access | Times Cited: 3
Squalene monooxygenase facilitates bladder cancer development in part by regulating PCNA
Changyan Zhu, Xiao Fang, Xiangshen Liu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2024) Vol. 1871, Iss. 3, pp. 119681-119681
Open Access | Times Cited: 3
The role of DGAT1 and DGAT2 in tumor progression via fatty acid metabolism: A comprehensive review
Leisheng Wang, Shiwei Xu, Mengzhen Zhou, et al.
International Journal of Biological Macromolecules (2024) Vol. 278, pp. 134835-134835
Open Access | Times Cited: 3
Cholesterol-Lowering Drugs on Akt Signaling for Prevention of Tumorigenesis
Navneet Kumar, Chandi C. Mandal
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 18
Synergistic Anti-Tumor Effect of Simvastatin Combined to Chemotherapy in Osteosarcoma
Adèle Mangelinck, Nadia Habel, Audrey Mohr, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5869-5869
Open Access | Times Cited: 18
Use of cholesterol metabolism for anti-cancer strategies
Meran Keshawa Ediriweera
Drug Discovery Today (2022) Vol. 27, Iss. 11, pp. 103347-103347
Closed Access | Times Cited: 13
ABCA9, an ER cholesterol transporter, inhibits breast cancer cell proliferation via SREBP‐2 signaling
Hyeon‐Ji Hwang, Kang‐Hoon Lee, Je‐Yoel Cho
Cancer Science (2022) Vol. 114, Iss. 4, pp. 1451-1463
Open Access | Times Cited: 13
Pre-operative levels of angiopoietin protein-like 3 (ANGPTL3) in women diagnosed with high-grade serous carcinoma of the ovary
Emilie Wong Chong, France‐Hélène Joncas, Pierre Douville, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Compartmentalized activities of HMGCS1 control cervical cancer radiosensitivity
Xiaomin Zhang, Congcong Sun, Jinliang Wan, et al.
Cellular Signalling (2022) Vol. 101, pp. 110507-110507
Closed Access | Times Cited: 12
2-Hydroxypropyl-β-cyclodextrin (HPβCD) as a Potential Therapeutic Agent for Breast Cancer
Sourav Saha, Naaziyah Abdulla, Tawanda Zininga, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2828-2828
Open Access | Times Cited: 6
Targeting cholesterol impairs cell invasion of all breast cancer types
Mauriane Maja, Marie Verfaillie, Patrick Van Deŕ Smissen, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
The role of cholesterol metabolism in lung cancer
Weigang Xiu, XINGYU LIU, KAIXIN HU, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 10, pp. 1613-1621
Open Access | Times Cited: 2
Erianin inhibits the progression of triple-negative breast cancer by suppressing SRC-mediated cholesterol metabolism
Ming Li, Shiyao Kang, Xuming Deng, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Potential molecular metabolic mechanisms underlying the effects of cimifugin in gastric cancer through single-cell and bulk RNA sequencing combined with network pharmacology
Ziming Zhu, Yinbiao Zhang, Xinyue Zhang, et al.
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 4, pp. 1409-1430
Open Access | Times Cited: 2
Lipid metabolism reprogramming in endometrial cancer: biological functions and therapeutic implications
Xiangyu Wang, Yinuo Li, Xin Hou, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Alterations of the chemical profile of cholesterol in cancer tissue as traced with ToF-SIMS
Auraya Manaprasertsak, Julhash U. Kazi, Catharina Hagerling, et al.
The Analyst (2024) Vol. 149, Iss. 21, pp. 5344-5352
Open Access | Times Cited: 2
A new enhancer for anti-PD-1/PD-L1 immunotherapy: PCSK9 inhibition
Shengbo Sun, Zhengyang Yang, Hongwei Yao, et al.
Trends in cancer (2024)
Closed Access | Times Cited: 2
The Use of the QbD Approach to Optimize the Co-Loading of Simvastatin and Doxorubicin in Liposomes for a Synergistic Anticancer Effect
Cristina Barbălată, Alina Porfire, Tibor Casian, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 10, pp. 1211-1211
Open Access | Times Cited: 9
Additive pre-diagnostic and diagnostic value of routine blood-based biomarkers in the detection of colorectal cancer in the UK Biobank cohort
Gizem Tanriver, Ece Kocagöncü
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Clinical Evidence of Interaction between Nutraceutical Supplementation and Platinum-based Chemotherapy
Veronica Cocetta, Mattia Tinazzi, Isabella Giacomini, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 19, pp. 2141-2164
Closed Access | Times Cited: 8
Research progress on the role of cholesterol in hepatocellular carcinoma
Peng Li, Qi Yan, Zhaolin Chen, et al.
European Journal of Pharmacology (2022) Vol. 938, pp. 175410-175410
Closed Access | Times Cited: 8
The utility of 3D models to study cholesterol in cancer: Insights and future perspectives
Thea-Leonie du Plessis, Naaziyah Abdulla, Mandeep Kaur
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Effect of selinexor on lipogenesis in virus-positive Merkel cell carcinoma cell lines
Jennifer R. Landes, Brooke R. Bartley, Stephen A. Moore, et al.
Clinical and Experimental Dermatology (2023) Vol. 48, Iss. 8, pp. 903-908
Closed Access | Times Cited: 4

Scroll to top